Respiratory News and Research

RSS

FEV1 poor mortality predictor in elderly

Research shows that forced expiratory volume in 1 second % predicted is ineffective for predicting mortality in elderly asthma patients.

18 Oct 2013

Astrazeneca, Taiwan's NRPB Launch Drug Discovery Collaboration

...

18 Oct 2013

Diaphragm pacing systems improve quality of life for ALS patients

Respiratory failure is one of the major complications associated with amyotrophic lateral sclerosis. The quest for alternative approaches for treating respiratory failure has led to the study, and subsequent FDA approval, of diaphragm pacing for use in ALS patients. However, there are still important unanswered questions about its benefit and impact.

18 Oct 2013

Researchers identify novel gene mutation that causes common variable immunodeficiency

A 30-year-old woman with a history of upper respiratory infections had no idea she carried an immunodeficiency disorder - until her 6-year-old son was diagnosed with the same illness.

18 Oct 2013

Clinical attention improves QoL in COPD

A study in the primary care setting shows that clinical factors have the greatest influence on improving health-related quality of life in patients with chronic obstructive pulmonary disease.

17 Oct 2013

Astrazeneca, Taiwan's NRPB Launch Drug Discovery Collaboration

...

17 Oct 2013

Discovery Labs submits IND application to start AEROSURF phase 2 clinical program

Discovery Laboratories, Inc., a specialty biotechnology company dedicated to advancing a new standard of respiratory critical care, today announced that it has submitted an investigational new drug application to the U.S. Food and Drug Administration to initiate its AEROSURF phase 2 clinical program.

17 Oct 2013

Researchers receive grant to accelerate development of mobile seizure alert system for epilepsy patients

Approximately 2 million people, including 400,000 children, in the United States are being treated for epilepsy, and one-third continue to have seizures despite treatment. In order to address an important caregiver need, RTI International has been developing a prototype mobile seizure alert system to help epilepsy patients and their families cope with seizures.

17 Oct 2013

New method to display viral DNA in host cells at single-molecule resolution

The medical, humanitarian and economical impact of viral diseases is devastating to humans and livestock. There are no adequate therapies available against most viral diseases, largely because the mechanisms by which viruses infect cells are poorly known.

17 Oct 2013

Air pollution hampers fetal growth

Exposure to common air pollutants and traffic during pregnancy significantly increases the risk of restricted fetal growth, even at levels well below those stipulated in current European Union (EU) air-quality directives, according to one of the largest studies of its kind, published in The Lancet Respiratory Medicine.

17 Oct 2013

Respicardia awarded U.S. Healthcare Product of the Year for remede System

Respicardia®, Inc., a developer of implantable therapies to improve respiratory and cardiovascular health, announced that it has been awarded the U.S. Healthcare Product of the Year by Acquisition International for the remede System, the first and only implantable device for the treatment of central sleep apnea.

16 Oct 2013

Phase 3 ODYSSEY MONO trial with alirocumab meets primary efficacy endpoint

Sanofi and Regeneron Pharmaceuticals, Inc. today announced that the Phase 3 ODYSSEY MONO trial with alirocumab, an investigational monoclonal antibody targeting PCSK9 (proprotein convertase subtilisin/kexin type 9), met its primary efficacy endpoint.

16 Oct 2013

Sexual dysfunction ‘ignored in COPD’

Researchers say that physicians should address sexual issues in patients with chronic obstructive pulmonary disease as a matter of course, after finding that over three-quarters of men with the condition have some level of erectile dysfunction.

15 Oct 2013

Astrazeneca Acquires Spirogen For Up To $440M

...

15 Oct 2013

Emergency departments across Michigan are more prepared to handle natural disaster

Emergency Departments across Michigan are better prepared to handle a disaster today than they were seven years ago, according to a Henry Ford Hospital study.

15 Oct 2013

Teva gets FDA approval for generic version of TOBI in US

Teva Pharmaceutical Industries Ltd. announces today that the U.S. Food and Drug Administration has granted approval of the generic equivalent to TOBI (Tobramycin Inhalation Solution USP) in the United States.

15 Oct 2013

AstraZeneca announces Phase III study results of naloxegol in patients with non-cancer pain

AstraZeneca (NYSE: AZN) today announced the results of a Phase III long-term safety and tolerability study of the once-daily 25mg dose of naloxegol, in patients with non-cancer pain and opioid-induced constipation (OIC).

15 Oct 2013

No link to air toxics in pediatric asthma prevalence

A nationwide US study has found that early exposure to ambient air toxics does not associate with the prevalence of asthma in young children.

14 Oct 2013

Drug treatment ineffective for acute bronchitis

A study published in the BMJ indicates that neither oral antibiotics nor nonsteroidal anti-inflammatory drugs are more effective than placebo for the treatment of acute bronchitis.

14 Oct 2013

GE Healthcare to introduce new technologies at ANESTHESIOLOGY 2013

GE Healthcare will introduce several new technologies that demonstrate its ongoing commitment to improving the quality of patient care at ANESTHESIOLOGY 2013, the annual meeting of the American Society of Anesthesiologists, taking place October 12-16 in San Francisco.

12 Oct 2013